SENTRY

First Orion Ushers in New Era of Outbound Call Spoof Protection with Launch of SENTRY

Retrieved on: 
Tuesday, October 10, 2023
Identity theft, Human, CCAA, SENTRY, Communication, Insurance, ISO/IEC 27001:2013, API, UCAA, Telecommunications, Sales, Online shopping, Risk management

This innovative authentication solution allows enterprises to proactively block fraudulent, spoofed outbound calls and ensures their numbers are only used for legitimate calls.

Key Points: 
  • This innovative authentication solution allows enterprises to proactively block fraudulent, spoofed outbound calls and ensures their numbers are only used for legitimate calls.
  • Account takeover fraud is one of the most common forms of identity theft and often involves scammers illegally spoofing phone numbers associated with reputable businesses.
  • The survey also found that four out of five respondents believed they received a phone call from a spoofed number.
  • To learn more about SENTRY and how it protects enterprises from having their numbers spoofed, visit firstorion.com/sentry/ .

IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

Retrieved on: 
Thursday, September 7, 2023
Health, Infectious Diseases, COVID-19, Research, Science, Pharmaceutical, Biotechnology, Abstract, Inc., Doctor of Pharmacy, Senior, SARS-CoV-2, Infection, Safety, Hospital, Head, Achromobacter, Stenotrophomonas maltophilia, Part, Non, Pseudomonas aeruginosa, Acquisition, Centre for Industry Education Collaboration, DTR, Learning, Effectiveness, Site, Patient, Sense, Randomized controlled trial, Generic, SENTRY, Treatment, Interim analysis, Pharmaceutical industry, Shionogi, Ensitrelvir

: S-217622, hereafter “ensitrelvir”), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcroja® in Europe.

Key Points: 
  • : S-217622, hereafter “ensitrelvir”), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcroja® in Europe.
  • Shionogi recently extended its infectious disease innovation platform with the acquisition of Qpex Biopharma Inc. (Qpex) in July.
  • The acquisition brings a novel investigational ß-lactamase inhibitor to Shionogi, expanding the company’s pipeline of critically needed antimicrobials, and further augmenting its R&D capabilities and expertise.
  • During IDWeek, Shionogi will host a Learning Lounge with David Nicolau, PharmD, titled Fetroja® (cefiderocol), An Overview of In Vitro and Clinical Data on Friday, October 13, from 10:15 – 11:00 AM ET.

Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Retrieved on: 
Monday, May 1, 2023
Research, Pharmaceutical, Optical, Medical Devices, Clinical Trials, Science, Surgery, Biotechnology, Medical Supplies, Other Science, Health, Diabetes, Ophthalmology, ASCRS, Zimmer Biomet Robotics, Patient, OCT, Randomized controlled trial, News, NYSE, Glaucoma, Trifocal lenses, Capsulorhexis, Electronic, Intraocular pressure, EEG microstates, Cataract, Cataract surgery, Refractive surgery, SENTRY, American Society of Cataract and Refractive Surgery, Phacoemulsification, Intraocular lens, Micheletti, IOP, Surgeon, ABO, Vision system, Refraction, Trial of the century, Annual general meeting, IOL, Society, Veterinary medicine, Telescopic sight, Medical device, Dentistry, Alcon, MD

Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .

Key Points: 
  • Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .
  • “The pace of innovation happening across eye care is extraordinary, and as the industry leader, we are excited to be leading the charge at ASCRS 2023,” said Sergio Duplan, President, North America at Alcon.
  • evaluates a head-to-head comparison of distance and intermediate vision of Clareon monofocal IOL and TECNIS Eyhance* monofocal IOL.
  • For information on Alcon events and news at ASCRS, please visit MyAlconatASCRS.com .

Air-Quality Monitoring Leader AirLogics Unveils New Technology, Executive Team

Retrieved on: 
Thursday, November 18, 2021
Software, Networks, Other Natural Resources, Data Management, Technology, Natural Resources, Commercial Building & Real Estate, Other Manufacturing, Construction & Property, Environment, Building Systems, Other Technology, Manufacturing, Operations management, Airlog, Solvent, GZA, Organic compound, Industry, Noise, Pids, Dust, GC, PID, Gas plant, Telemetry, Solution, Mike Hudock, Goal, SENTRY, Radio, LLC, Nitrogen dioxide, Atmosphere, AQS, MGP, Ozone, VOC, Volatile organic compound, Management, Risk management, Environmental remediation

AirLogics, a leading national provider of air quality monitoring solutions, today announced an expanded suite of technologies and measuring capabilities, a revamped company website, and new senior executive leadership.

Key Points: 
  • AirLogics, a leading national provider of air quality monitoring solutions, today announced an expanded suite of technologies and measuring capabilities, a revamped company website, and new senior executive leadership.
  • The companys capabilities also include supporting demolition, indoor air quality measurement, industrial and commercial applications, and neighborhood air quality/environmental justice monitoring initiatives.
  • Among new technologies and capabilities AirLogics is announcing today:
    New lightweight, mobile AQS-1 and DUST SENTRY air monitoring systems manufactured for AirLogics by AeroQual , which can detect total volatile organic compounds (VOCs) and dust in real time.
  • Use of a new photoionization detector (PID) in the AirLogics SolarLite system, custom-made for AirLogics.